GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SSB · Dec 31, 2025

SouthState Bank Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-26-017884Bank
Sequential deposit growth70thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.98% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

49.34% · CORE · VALID

Interest-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

57.82% · CORE · VALID

Cash and equivalents55thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$3.2B · CORE · VALID

Sequential loan growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.99% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
0.70%
Current
1.98%
Delta
1.28%
Earnings Growth Decreased
Previous
72.26%
Current
49.34%
Delta
-22.92%
Interest Income Growth Decreased
Previous
62.02%
Current
57.82%
Delta
-4.20%
Liquidity Increased
Previous
$3.1B
Current
$3.2B
Delta
$28.0M
Loan Growth Increased
Previous
0.93%
Current
1.99%
Delta
1.06%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.